Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Assisted Reproduction and Genetics
Erschienen in: Journal of Assisted Reproduction and Genetics 5/2017

09.03.2017 | Review

Role of DNA methylation in imprinting disorders: an updated review

verfasst von: Amr Rafat Elhamamsy

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Genomic imprinting is a complex epigenetic process that contributes substantially to embryogenesis, reproduction, and gametogenesis. Only small fraction of genes within the whole genome undergoes imprinting. Imprinted genes are expressed in a monoallelic parent-of-origin-specific manner, which means that only one of the two inherited alleles is expressed either from the paternal or maternal side. Imprinted genes are typically arranged in clusters controlled by differentially methylated regions or imprinting control regions. Any defect or relaxation in imprinting process can cause loss of imprinting in the key imprinted loci. Loss of imprinting in most cases has a harmful effect on fetal development and can result in neurological, developmental, and metabolic disorders. Since DNA methylation and histone modifications play a key role in the process of imprinting. This review focuses on the role of DNA methylation in imprinting process and describes DNA methylation aberrations in different imprinting disorders.
Literatur
1.
Feil R, Berger F. Convergent evolution of genomic imprinting in plants and mammals. Trends Genet. 2007;23(4):192–9.PubMedCrossRef
2.
Chao W. Genomic imprinting. Handb Epigenetics. 2011; p. 353–79.
3.
4.
Maupetit-Méhouas S, Montibus B, Nury D, Tayama C, Wassef M, Kota SK, et al. Imprinting control regions (ICRs) are marked by mono-allelic bivalent chromatin when transcriptionally inactive. Nucleic Acids Res. 2016;44:621–35.PubMedCrossRef
5.
6.
Rougeulle C, Glatt H, Lalande M. The Angelman syndrome candidate gene, UBE3A/E6-AP, is imprinted in brain. Nat Genet. 1997;17:14–5.PubMedCrossRef
7.
Lalande M, Calciano MA. Molecular epigenetics of Angelman syndrome. Cell Mol Life Sci. 2007; p. 947–60.
8.
Bastepe M. The GNAS locus and pseudohypoparathyroidism. Adv Exp Med Biol. 2008; p. 27–40.
9.
10.
Iglesias-Platas I, Court F, Camprubi C, Sparago A, Guillaumet-Adkins A, Martin-Trujillo A, et al. Imprinting at the PLAGL1 domain is contained within a 70-kb CTCF/cohesin-mediated non-allelic chromatin loop. Nucleic Acids Res. 2013;41:2171–9.PubMedPubMedCentralCrossRef
11.
Baran Y, Subramaniam M, Biton A, Tukiainen T, Tsang EK, Rivas MA, et al. The landscape of genomic imprinting across diverse adult human tissues. Genome Res. 2015;25:927–36.PubMedPubMedCentralCrossRef
12.
13.
Messerschmidt DM, Knowles BB, Solter D. DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos. Genes Dev. 2014:812–28.
14.
15.
Cantone I, Fisher AG. Epigenetic programming and reprogramming during development. Nat Struct Mol Biol. 2013;20:282–9.
16.
Morgan HD, Santos F, Green K, Dean W, Reik W. Epigenetic reprogramming in mammals. Hum. Mol. Genet. 2005.
17.
18.
19.
Paczkowski M, Schoolcraft WB, Krisher RL. Dysregulation of methylation and expression of imprinted genes in oocytes and reproductive tissues in mice of advanced maternal age. J Assist Reprod Genet. 2015;32:713–23.PubMedPubMedCentralCrossRef
20.
Elhamamsy AR. DNA methylation dynamics in plants and mammals: overview of regulation and dysregulation. Cell Biochem Funct. 2016;34(5):289–98.PubMedCrossRef
21.
Sha K. A mechanistic view of genomic imprinting. Annu Rev Genomics Hum Genet. 2008;9:197–216.PubMedCrossRef
22.
Sleutels F, Zwart R, Barlow DP. The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature. 2002;415:810–3.PubMedCrossRef
23.
Royo H, Cavaillé J. Non-coding RNAs in imprinted gene clusters. Biol Cell. 2008;100:149–66.PubMedCrossRef
24.
Pandey RR, Mondal T, Mohammad F, Enroth S, Redrup L, Komorowski J, et al. Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell. 2008;32:232–46.PubMedCrossRef
25.
Chiesa N, De Crescenzo A, Mishra K, Perone L, Carella M, Palumbo O, et al. The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases. Hum Mol Genet. 2012;21:10–25.PubMedCrossRef
26.
27.
Higashimoto K, Soejima H, Saito T, Okumura K, Mukai T. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer. Cytogenet Genome Res. 2006; p. 306–12.
28.
Ulaner GA, Yang Y, Hu JF, Li T, Vu TH, Hoffman AR. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues. Endocrinology. 2003;144:4420–6.PubMedCrossRef
29.
Beygo J, Citro V, Sparago A, De Crescenzo A, Cerrato F, Heitmann M, et al. The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites. Hum Mol Genet. 2013;22:544–57.PubMedCrossRef
30.
Demars J, Gicquel C. Epigenetic and genetic disturbance of the imprinted 11p15 region in Beckwith-Wiedemann and Silver-Russell syndromes. Clin Genet. 2012; p. 350–61.
31.
Jacob K, Robinson WP, Lefebvre L. Beckwith-Wiedemann and Silver-Russell syndromes: opposite developmental imbalances in imprinted regulators of placental function and embryonic growth. Clin Genet. 2013;84:326–34.PubMedCrossRef
32.
33.
Horsthemke B. In brief: genomic imprinting and imprinting diseases. J Pathol. 2014;232:485–7.PubMedCrossRef
34.
Wilkins JF, Úbeda F. Diseases associated with genomic imprinting. Prog Mol Biol Transl Sci. 2011;101:401–45.PubMedCrossRef
35.
Yamazawa K, Ogata T, Ferguson-Smith AC. Uniparental disomy and human disease: an overview. Am J Med Genet Part C Semin Med Genet. 2010; p. 329–34.
36.
Horsthemke B. Mechanisms of imprint dysregulation. Am. J. Med. Genet. Part C Semin. Med. Genet. 2010. p. 321–8.
37.
Delaval K, Wagschal A, Feil R. Epigenetic deregulation of imprinting in congenital diseases of aberrant growth. BioEssays. 2006; p. 453–9.
38.
Amor DJ, Halliday J. A review of known imprinting syndromes and their association with assisted reproduction technologies. Hum. Reprod. 2008. p. 2826–34.
39.
Iliadou AN, Janson PCJ, Cnattingius S. Epigenetics and assisted reproductive technology. J Intern Med. 2011; p. 414–20.
40.
41.
Lazaraviciute G, Kauser M, Bhattacharya S, Haggarty P, Bhattacharya S. A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously. Hum Reprod Update. 2014;20:840–52.PubMedCrossRef
42.
MacKay DJG, Eggermann T, Buiting K, Garin I, Netchine I, Linglart A, et al. Multilocus methylation defects in imprinting disorders. Biomol Concepts. 2015:47–57.
43.
Sanchez-Delgado M, Riccio A, Eggermann T, Maher ER, Lapunzina P, Mackay D, et al. Causes and consequences of multi-locus imprinting disturbances in humans. Trends Genet. 2016. p. 444–55.
44.
Arima T, Kamikihara T, Hayashida T, Kato K, Inoue T, Shirayoshi Y, et al. ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith–Wiedemann syndrome. Nucleic Acids Res. 2005;33:2650–60.
45.
Mackay DJG, Boonen SE, Clayton-Smith J, Goodship J, Hahnemann JMD, Kant SG, et al. A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet. 2006;120:262–9.PubMedCrossRef
46.
47.
Court F, Martin-Trujillo A, Romanelli V, Garin I, Iglesias-Platas I, Salafsky I, et al. Genome-wide allelic methylation analysis reveals disease-specific susceptibility to multiple methylation defects in imprinting syndromes. Hum Mutat. 2013;34:595–602.PubMed
48.
Perez-Nanclares G, Romanelli V, Mayo S, Garin I, Zazo C, Fernandez-Rebollo E, et al. Detection of hypomethylation syndrome among patients with epigenetic alterations at the GNAS locus. J Clin Endocrinol Metab. 2012;97.
49.
Rossignol S, Steunou V, Chalas C, Kerjean A, Rigolet M, Viegas-Pequignot E, et al. The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region. J Med Genet. 2006;43:902–7.PubMedPubMedCentralCrossRef
50.
Boonen SE, Mackay DJG, Hahnemann JMD, Docherty L, Gronskov K, Lehmann A, et al. Transient neonatal diabetes, ZFP57, and hypomethylation of multiple imprinted loci. Diabetes Care. 2013;36:505–12.PubMedPubMedCentralCrossRef
51.
Mackay DJG, Hahnemann JMD, Boonen SE, Poerksen S, Bunyan DJ, White HE, et al. Epimutation of the TNDM locus and the Beckwith-Wiedemann syndrome centromeric locus in individuals with transient neonatal diabetes mellitus. Hum Genet. 2006;119:179–84.PubMedCrossRef
52.
Gardner RJ, Mackay DJ, Mungall AJ, Polychronakos C, Siebert R, Shield JP, et al. An imprinted locus associated with transient neonatal diabetes mellitus. Hum Mol Genet. 2000;9:589–96.PubMedCrossRef
53.
54.
Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet. 2005;37:1003–7.PubMedCrossRef
55.
Netchine I, Rossignol S, Dufourg MN, Azzi S, Rousseau A, Perin L, et al. Brief report: 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab. 2007;92:3148–54.PubMedCrossRef
56.
57.
58.
59.
60.
Habib WA, Azzi S, Brioude F, Steunou V, Thibaud N, Das Neves C, et al. Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome. Hum Mol Genet. 2014;23:5763–73.CrossRef
61.
Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2010;18:8–14.
62.
63.
64.
Netchine I, Rossignol S, Azzi S, Brioude F, Bouc YL. Imprinted anomalies in fetal and childhood growth disorders: the model of Russell-Silver and Beckwith-Wiedemann syndromes. Dev Biol GH Secretion, Growth Treat. 2012; p. 60–70.
65.
Brioude F, Lacoste A, Netchine I, Vazquez MP, Auber F, Audry G, et al. Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance. Horm Res Paediatr. 2014;80:457–65.CrossRef
66.
67.
Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S, Nicholls RD, et al. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat Genet. 1995;9:395–400.PubMedCrossRef
68.
69.
70.
de Smith AJ, Purmann C, Walters RG, Ellis RJ, Holder SE, Van Haelst MM, et al. A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum Mol Genet. 2009;18:3257–65.PubMedPubMedCentralCrossRef
71.
Horsthemke B, Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region. Am J Med Genet Part A. 2008; p. 2041–52.
72.
Malzac P, Webber H, Moncla A, Graham JM, Kukolich M, Williams C, et al. Mutation analysis of UBE3A in Angelman syndrome patients. Am J Hum Genet. 1998;62:1353–60.PubMedPubMedCentralCrossRef
73.
Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997;15:74–7.PubMedCrossRef
74.
Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70–3.PubMedCrossRef
75.
76.
77.
78.
79.
Linglart A, Bastepe M, Jüppner H. Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clin Endocrinol. 2007;67:822–31.CrossRef
80.
Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest. 2000;106:1167–74.PubMedPubMedCentralCrossRef
81.
Bastepe M, Altug-Teber O, Agarwal C, Oberfield SE, Bonin M, Jüppner H. Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib). Bone. 2011;48:659–62.PubMedCrossRef
82.
83.
Shield JP, Gardner RJ, Wadsworth EJ, Whiteford ML, James RS, Robinson DO, et al. Aetiopathology and genetic basis of neonatal diabetes. Arch Dis Child Fetal Neonatal Ed. 1997;76:F39–42.
84.
85.
86.
Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med. 2006;355:456–66.
87.
Vaxillaire M, Dechaume A, Busiah K, Cave H, Pereira S, Scharfmann R, et al. New ABCC8 mutations in relapsing neonatal diabetes and clinical features. Diabetes. 2007;56:1737–41.PubMedCrossRef
88.
Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes. 2005; p. 2503–13.
89.
Anik A, Çatli G, Abaci A, Yiş U, Ören H, Güleryüz H, et al. A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis. J Pediatr Endocrinol Metab. 2014;27:533–7.PubMed
90.
Temple IK, Gardner RJ, Robinson DO, Kibirige MS, Ferguson AW, Baum JD, et al. Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23. Hum Mol Genet. 1996;5:1117–21.PubMedCrossRef
91.
Das S, Lese CM, Song M, Jensen JL, Wells LA, Barnoski BL, et al. Partial paternal uniparental disomy of chromosome 6 in an infant with neonatal diabetes, macroglossia, and craniofacial abnormalities. Am J Hum Genet. 2000;67:1586–91.PubMedPubMedCentralCrossRef
92.
Baglivo I, Esposito S, De CL, Sparago A, Anvar Z, Riso V, et al. Genetic and epigenetic mutations affect the DNA binding capability of human ZFP57 in transient neonatal diabetes type 1. FEBS Lett. 2013;587:1474–81.PubMedPubMedCentralCrossRef
93.
Temple IK, Shield JPH. 6q24 transient neonatal diabetes. Rev Endocr Metab Disord. 2010;11:199–204.PubMedCrossRef
94.
Takikawa S, Wang X, Ray C, Vakulenko M, Bell FT, Li X. Human and mouse ZFP57 proteins are functionally interchangeable in maintaining genomic imprinting at multiple imprinted regions in mouse ES cells. Epigenetics. 2013;8:1268–79.PubMedPubMedCentralCrossRef
95.
Ideraabdullah FY, Bartolomei MS. ZFP57: KAPturing DNA methylation at imprinted loci. Mol Cell. 2011; p. 341–2.
96.
Yada T, Sakurada M, Ishihara H, Nakata M, Shioda S, Yaekura K, et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats. J Physiol. 1997;505:319–28.PubMedPubMedCentralCrossRef
97.
Ciani E, Hoffmann A, Schmidt P, Journot L, Spengler D. Induction of the PAC1-R (PACAP-type I receptor) gene by p53 and Zac. Mol Brain Res. 1999;69:290–4.PubMedCrossRef
98.
99.
Mackay DJG, Temple IK. Transient neonatal diabetes mellitus type 1. Am. J. Med. Genet. Part C Semin. Med. Genet. 2010. p. 335–42.
100.
101.
Iglesias-Platas I, Martin-Trujillo A, Petazzi P, Guillaumet-Adkins A, Esteller M, Monk D. Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta. Hum Mol Genet. 2014;23:6275–85.PubMedPubMedCentralCrossRef
102.
Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, Aknin C, et al. Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell. 2006;11:711–22.PubMedCrossRef
103.
Kameswaran V, Kaestner KH. The missing lnc(RNA) between the pancreatic β-cell and diabetes. Front Genet. 2014;5.
104.
105.
Valleley EM, Cordery SF, Bonthron DT. Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters. Hum Mol Genet. 2007;16:972–81.PubMedCrossRef
106.
Piras G, El Kharroubi A, Kozlov S, Escalante-Alcalde D, Hernandez L, Copeland NG, et al. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines. Mol Cell Biol. 2000;20:3308–15.PubMedPubMedCentralCrossRef
107.
Mackay DJG, Coupe AM, Shield JPH, Storr JNP, Temple IK, Robinson DO. Relaxation of imprinted expression of ZAC and HYMAI in a patient with transient neonatal diabetes mellitus. Hum Genet. 2002;110:139–44.PubMedCrossRef
108.
Peille AL, Brouste V, Kauffmann A, Lagarde P, Le Morvan V, Coindre JM, et al. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas. PLoS One. 2013;8.
109.
Kamikihara T, Arima T, Kato K, Matsuda T, Kato H, Douchi T, et al. Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer. Int J Cancer. 2005;115:690–700.PubMedCrossRef
110.
111.
Rossignol S, Netchine I, Le Bouc Y, Gicquel C. Epigenetics in Silver-Russell syndrome. Best Pract Res Clin Endocrinol Metab. 2008; p. 403–14.
112.
Monk D, Bentley L, Hitchins M, Myler RA, Clayton-Smith J, Ismail S, et al. Chromosome 7p disruptions in Silver Russell syndrome: delineating an imprinted candidate gene region. Hum Genet. 2002;111:376–87.PubMedCrossRef
113.
114.
Eggermann T. Epigenetic regulation of growth: lessons from Silver-Russell syndrome. Endocr Dev. 2009; p. 10–9.
115.
116.
117.
Pettenati MJ, Haines JL, Higgins RR, Wappner RS, Palmer CG, Weaver DD. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet. 1986;74:143–54.PubMedCrossRef
118.
Ward A. Beckwith-Wiedemann syndrome and Wilms’ tumour. Mol Hum Reprod. 1997;3.
119.
Weksberg R, Nishikawa J, Caluseriu O, Fei YL, Shuman C, Wei C, et al. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet. 2001;10:2989–3000.
120.
121.
Choufani S, Shuman C, Weksberg R. Molecular findings in Beckwith-Wiedemann syndrome. Am J Med Genet Part C Semin Med Genet. 2013;163:131–40.CrossRef
122.
Kanduri C. Kcnq1ot1: a chromatin regulatory RNA. Semin. Cell Dev Biol. 2011; p. 343–50.
123.
Choufani S, Shuman C, Weksberg R. Beckwith-Wiedemann syndrome. Am J Med Genet Part C Semin Med Genet. 2010; p. 343–54.
124.
Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell. 2008; p. 159–69.
125.
126.
Eggermann T. Silver-Russell and Beckwith-Wiedemann syndromes: opposite (epi)mutations in 11p15 result in opposite clinical pictures. Horm Res. 2009; p. 30–5.
127.
Lewis A, Green K, Dawson C, Redrup L, Huynh KD, Lee JT, et al. Epigenetic dynamics of the Kcnq1 imprinted domain in the early embryo. Development. 2006;133:4203–10.PubMedCrossRef
128.
Demars J, Shmela ME, Rossignol S, Okabe J, Netchine I, Azzi S, et al. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet. 2010;19:803–14.PubMedCrossRef
129.
130.
Calvello M, Tabano S, Colapietro P, Maitz S, Pansa A, Augello C, et al. Quantitative DNA methylation analysis improves epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. Epigenetics. 2013;8:1053–60.PubMedPubMedCentralCrossRef
131.
Paganini L, Carlessi N, Fontana L, Silipigni R, Motta S, Fiori S, et al. Beckwith-Wiedemann syndrome prenatal diagnosis by methylation analysis in chorionic villi. Epigenetics. 2015;10:643–9.PubMedPubMedCentralCrossRef
132.
Burd L, Vesely B, Martsolf J, Kerbeshian J. Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet. 1990;37:97–9.PubMedCrossRef
133.
Ehara H, Ohno K, Takeshita K. Frequency of the Prader-Willi syndrome in the San-in district, Japan. Brain Dev. 1995;17:324–6.PubMedCrossRef
134.
135.
Rodriguez-Jato S, Nicholls RD, Driscoll DJ, Yang TP. Characterization of cis- and trans-acting elements in the imprinted human SNURF-SNRPN locus. Nucleic Acids Res. 2005;33:4740–53.PubMedPubMedCentralCrossRef
136.
Perk J, Makedonski K, Lande L, Cedar H, Razin A, Shemer R. The imprinting mechanism of the Prader-Willi/Angelman regional control center. EMBO J. 2002;21:5807–14.PubMedPubMedCentralCrossRef
137.
Runte M, Hüttenhofer A, Groß S, Kiefmann M, Horsthemke B, Buiting K. The IC-SNURF–SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum Mol Genet. 2001;10:2687–700.
138.
Will CL, Lührmann R. Spliceosome structure and function. Cold Spring Harb Perspect Biol. 2011;3:1–2.CrossRef
139.
Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 2008;17:111–8.PubMedCrossRef
140.
Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, Flavell SW, et al. The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell. 2010;140:704–16.PubMedPubMedCentralCrossRef
141.
Ferdousy F, Bodeen W, Summers K, Doherty O, Wright O, Elsisi N, et al. Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. Neurobiol Dis. 2011;41:669–77.PubMedCrossRef
142.
Buiting K. Prader-Willi syndrome and Angelman syndrome. Am J Med Genet Part C Semin Med Genet. 2010; p. 365–76.
143.
Elena G, Bruna C, Benedetta M, Stefania DC, Giuseppe C. Prader-Willi syndrome: clinical aspects. J. Obes. 2012.
144.
Butler MG. Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet. 2009; p. 477–86.
145.
146.
Mertz LGB, Christensen R, Vogel I, Hertz JM, Nielsen KB, Grønskov K, et al. Angelman syndrome in Denmark. Birth incidence, genetic findings, and age at diagnosis. Am J Med Genet Part A. 2013;161:2197–203.CrossRef
147.
Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M. Autism in Angelman syndrome: a population-based study. Pediatr Neurol. 1996;14:131–6.PubMedCrossRef
148.
Runte M, Kroisel PM, Gillessen-Kaesbach G, Varon R, Horn D, Cohen MY, et al. SNURF-SNRPN and UBE3A transcript levels in patients with Angelman syndrome. Hum Genet. 2004;114:553–61.PubMedCrossRef
149.
150.
151.
Judson MC, Sosa-Pagan JO, Del Cid WA, Han JE, Philpot BD. Allelic specificity of Ube3a expression in the mouse brain during postnatal development. J Comp Neurol. 2014;522:1874–96.PubMedPubMedCentralCrossRef
152.
White HE, Hall VJ, Cross NCP. Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromes. Clin Chem. 2007;53:1960–2.PubMedCrossRef
153.
154.
Bastepe M. The GNAS locus: quintessential complex gene encoding Gsalpha, XLalphas, and other imprinted transcripts. Curr Genomics. 2007;8:398–414.PubMedPubMedCentralCrossRef
155.
156.
Turan S, Bastepe M. The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene. Horm Res Paediatr. 2013; p. 229–41.
157.
158.
Vilardaga JP, Romero G, Friedman PA, Gardella TJ. Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm. Cell Mol Life Sci. 2011; p. 1–13.
159.
160.
Plagge A, Kelsey G. Imprinting the Gnas locus. Cytogenet Genome Res. 2006; p. 178–87.
161.
Turan S, Ignatius J, Moilanen JS, Kuismin O, Stewart H, Mann NP, et al. De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases. J Clin Endocrinol Metab. 2012;97.
162.
Elli FM, De Sanctis L, Peverelli E, Bordogna P, Pivetta B, Miolo G, et al. Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A/B DMR. J Clin Endocrinol Metab. 2014;99.
Metadaten
Titel
Role of DNA methylation in imprinting disorders: an updated review
verfasst von
Amr Rafat Elhamamsy
Publikationsdatum
09.03.2017
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 5/2017
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-017-0895-5

Weitere Artikel der Ausgabe 5/2017

Journal of Assisted Reproduction and Genetics 5/2017 Zur Ausgabe

Erratum

Erratum to: Attempts to improve human ovarian transplantation outcomes of needle immersed vitrification and slow-freezing by host and graft treatments

Assisted Reproduction Technologies

Relationship between pre-ICSI meiotic spindle angle, ovarian reserve, gonadotropin stimulation, and pregnancy outcomes

Erratum

Erratum to: The association between coenzyme Q10 concentrations in follicular fluid with embryo morphokinetics and pregnancy rate in assisted reproductive techniques

Technological Innovations

Polar body transfer restores the developmental potential of oocytes to blastocyst stage in a case of repeated embryo fragmentation

Assisted Reproduction Technologies

Predictive value of spindle retardance in embryo implantation rate

Genetics

A no-stop mutation in MAGEB4 is a possible cause of rare X-linked azoospermia and oligozoospermia in a consanguineous Turkish family

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 | Depression antepartal oder postpartal | Nachrichten

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

20.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika
weitere anzeigen

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen